CoreAge Rx vs Rejuve Meds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Rejuve Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Rejuve Meds a bad call — it's best for readers comparing clinician-led injection programs who can resolve product-format labels and the selected plan’s complete payment terms. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Rejuve Meds |
|---|---|---|
| Brief Score | 94/100 (A) | 65/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Named injection starts at $299/month General weight-care banner starts at $179/month; selected dose, quantity and complete plan quote unconfirmed. Shipping is advertised free, but terms allow charges shown before payment; oral labels conflict with injection descriptions. Full price detailsCompounded semaglutide injection offered; complete selected-plan quote unknown; named product starts at $299/month versus general weight-care banner from $179/month; shipping terms and final supply require confirmation |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Named injection starts at $449/month Final prescribed quantity, plan interval and shipping-inclusive total require confirmation. Card-on-file refills recur until canceled; medication processing can end refund eligibility. Full price detailsCompounded tirzepatide injection offered; complete selected-plan quote unknown; named product starts at $449/month; final supplied quantity, term and any shipping charge require confirmation |
| Coverage | US only; restrictions by state, confirmed at intake | United States only; current treatment-specific state list and individual clinician/pharmacy eligibility are not established |
| Brand-name access | Not confirmed | Separate Wegovy and Zepbound programs are advertised; exact formulation, supplied quantity and total remain prescription-specific. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Rejuve Meds: Named injection pages start at $299 semaglutide/$449 tirzepatide, while general weight-care banner starts at $179. Full selected supply and shipping-inclusive total unconfirmed.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.